Catalyst Wire Dossier Catalyst Wire Dossier

TQB3201 tablets

TQB3201 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3201 tablets, covering 2025-09-15 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets [Phase 1, Phase 2]

See pricing